Caplin Point Laboratories Ltd.

Financial

	Caplin Point Lab	Gufic Biosciences	Gland Pharma
Operational Metrics
Pharmaceutical Sector
Number of ANDA's Filed in USA	46.0 .	n/a	366.0 .
Number of ANDA's Approved By USFDA	33.0 .	n/a	312.0 .
R&D as a % of Total Sales	4.4 %	0.83 %	4.3 %
Financials
5 yr Average ROE	20.61 %	25.05 %	14.74 %
5yr average Equity Multiplier	1.17	2.22	1.13
5yr Average Asset Turnover Ratio	0.72	1.05	0.53
5yr Avg Net Profit Margin	24.8 %	10.9 %	24.17 %
Price to Book	5.64	6.3	2.77
P/E	27.85	44.15	34.6
5yr Avg Cash Conversion Cycle	79.85 Days	26.94 Days	72.51 Days
Inventory Days	64.55 Days	66.86 Days	117.52 Days
Days Receivable	100.92 Days	128.09 Days	78.29 Days
Days Payable	74.04 Days	163.91 Days	103.04 Days
5yr Average Interest Coverage Ratio	579.71	13.1	205.64
5yr Avg ROCE	25.27 %	27.25 %	19.61 %
5yr Avg Operating Profit Margin	30.87 %	18.45 %	32.0 %
5 yr average Debt to Equity	0.01	0.51	0.01
5yr CAGR Net Profit	16.28 %	14.26 %	-0.01 %
5yr Average Return on Assets	17.7 %	11.52 %	13.18 %
Shareholdings
Promoter Holding	70.56 %	72.51 %	51.83 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	1.67 %	-2.97 %	-6.17 %
Change in Mutual Fund Holding (3 Yrs)	0.55 %	2.36 %	19.94 %

Business

	Caplin Point Lab	Gufic Biosciences	Gland Pharma
Product Wise Break-Up	Product Wise Break-Up Formulations 75.0 Branded Generics 25.0 API 0 Muscle Relaxants 0 Cardiovascular 0 Proton pump inhibitors 0 Anti-fungals 0 Anti-bacterials 0 International 0 CMO 0 Domestic 0 Injectables 0 Pharmaceuticals 0	Product Wise Break-Up Muscle Relaxants 0 Branded Generics 0 International 15.0 Proton pump inhibitors 0 CMO 30.0 Anti-fungals 0 Pharmaceuticals 0 Anti-bacterials 0 Active Pharmaceutical Ingredient (API) 5.0 Formulations 0 Cardiovascular 0 Injectables 0 Domestic Pharmaceuticals 50.0	Product Wise Break-Up Muscle Relaxants 0 Branded Generics 0 International 0 Proton pump inhibitors 0 CMO 0 Anti-fungals 0 Pharmaceutical 100.0 Anti-bacterials 0 API 0 Formulations 0 Cardiovascular 0 Injectables 0 Domestic 0
Location Wise Break-Up	Location Wise Break-Up Latin America 80.0 USA 18.0 Africa 2.0 India 0 South America 0 Australia 0 North America 0 Europe 0 Asia 0 Rest of the World 0 Canada, Australia & New Zealand 0 Canada 0	Location Wise Break-Up Canada 0 Australia 0.53 Africa 0.72 Asia Pacific 4.5 India 89.07 Rest of the World 0 USA 0 Canada, Australia & New Zealand 0 Latin America 0 Europe 3.67 North America 1.27 South America 0.23 Others 0.01	Location Wise Break-Up Canada 0 Australia 0 Africa 0 Asia 0 India 4.06 Rest of the World 0 USA 52.69 Canada, Australia & New Zealand 3.32 Latin America 0 Europe 19.12 North America 0 South America 0 Others 20.81
Distribution Channel	Distribution Channel Distribution 55.0 Pharmacy and Dietary 25.0 Tender Business 20.0 B2C 0 B2B 0	-	Distribution Channel Distribution 0 B2B 98.0 B2C 2.0 Pharmacy and Dietary 0 Tender Business 0
Manufacturing Break-Up	Manufacturing Break-Up India 75.0 China 25.0	-	-

Caplin Point Laboratories Ltd.

Caplin Point Laboratories Ltd.

SIGN UP FOR FREE